Birungi, Josephine Eun Min, Jeong A. Muldoon, Katherine Kaleebu, Pontiano King, Rachel Khanakwa, Sarah Nyonyintono, Maureen Chen, YaLin J. Mills, Edward Lyagoba, Fred Ragonnet-Cronin, Manon Wangisi, Jonathan Lourenco, Lillian M. Moore, David Study profile of the Highly Active Antiretroviral therapy as Prevention (HAARP) Study. <p>Study profile of the Highly Active Antiretroviral therapy as Prevention (HAARP) Study.</p> serodiscordant couples;Preventing HIV Infection;100 PYRs;HIV prevention tool;incidence rates;586 couples;Observational Study BackgroundWe;linked.ConclusionOverall HIV incidence;incidence rate ratio;seroconverting participants.ResultsA;eligibility criteria;HIV incidence;ci;HIV serodiscordant couples;linkage studies;1.5 years;Antiretroviral therapy;iii;HIV transmission;Hazard ratio;HIV seroconversion 2015-07-14
    https://plos.figshare.com/articles/figure/_Study_profile_of_the_Highly_Active_Antiretroviral_therapy_as_Prevention_HAARP_Study_/1482887
10.1371/journal.pone.0132182.g001